Next Generation Healthcare & Industrial Biotechnology Throw the Spotlight on Biosensors
Growing
use of biosensors in myriad medical and non-medical applications; rising
prominence of portable biosensor-based devices to manage health issues and
development of advanced and reliable biosensors are poised to drive the global Biosensors market to
reach US$28.3 billion by 2024. Biosensor or a biological sensor, which consists
of a physiochemical detector component (transducer) along with a biological
component, is used in the identification of an analyte or compound in a sample.
Biosensor-based devices are convenient, easy to use, sensitive and highly
accurate and can be used in a range of research and commercial applications.
Healthcare, food, aerospace, automotive, and agriculture industries are the
major application markets for biosensors. Growth in the global biosensors
market is being guided by the increasing use of biosensors in a diverse range
of medical and non-medical applications. Expanding application markets are
expected to play a critical part in the emergence of standardized equipment,
test processes, and types of molecules in areas such as bio-defense, narcotic
detection, drug discovery, and environmental monitoring.
Medical
applications of biosensors continue to dominate the global biosensors market.
Biosensors are being extensively used for the measurement of blood metabolites
such as glucose, urea, creatinine and lactate, among others. The increasing
incidence of chronic diseases specifically diabetes and the subsequent need for
diagnostic and monitoring devices, growing emphasis on home diagnostics, rising
significance of point of care (POC) testing,
and technological advancements in the areas of micro-fluids and nanotechnology
are propelling the biosensors market. The rising demand for simple,
easy-to-use, disposable and user friendly devices with faster response time is
fueling demand for biosensors in the medical sector. Point-of-care (PoC)
testing biosensors are playing a vital role in rapid and sensitive detection of
target analytes, enabling diagnosis of diseases such as infectious diseases,
diabetes, cardiovascular diseases and cancer. Biosensors market is also
expected to benefit from the growing prominence of personalized medicine as an
evolving treatment model.
While
clinical applications remain the mainstay of biosensors growth, the market is
also being propelled by the increasing use of biosensors in non-clinical
applications in the fields of agriculture, biotechnology, medicine, military,
industrial control, and for prevention and detection of bioterrorism.
Biosensors especially are exhibiting significant potential for
commercialization in food & beverage and environmental sampling markets.
Biosensors are being used in process industries to detect the presence of
biological contaminants and toxic compounds in pharmaceuticals and food
processing industries.
The
rapid pace of technology advancements, with focus especially on the development
of disposable, user-friendly and cost-efficient devices, is fostering growth in
the global biosensors market. Also, sustained increase in R&D investments is
leading to the emergence of new uses of biosensors that are expected to
transform the market in the coming years. Specifically wearable biosensors
technology is emerging as a promising technology led primarily by growing consumer
focus on leading healthy lifestyles.
As
stated by the new market research report on Biosensors, the United States represents
the largest regional market, worldwide. Rapid growth of PoC segment, due to its
role in early diagnosis and improve rate of patient recovery, is driving the
biosensors market. Biosensors’ adoption in the US will continue to increase led
by the growing need to prevent and treat chronic diseases. In particular, there
is growing demand for wearable biosensors, due to the increasing number of
people suffering from conditions such as diabetes, cancer and obesity-related
disorders. Asia-Pacific is forecast to register the fastest CAGR of 14.2% over
the analysis period, driven mainly by the rapidly rising incidence of lifestyle
diseases such as diabetes, an aging population, and greater access to
healthcare services in the region. Glucose monitoring devices, which make use
of biosensors, are in particular generating huge demand in Asia-Pacific.
Major
players in the market include Abbott Point of Care Inc., ABTECH Scientific
Inc., AgaMatrix Inc., Anitoa Systems LLC, Binergy Scientific Inc., Biolan
Microbiosensores S.L., Bio-Rad Laboratories Inc., Cambridge Life Sciences
Limited, F. Hoffmann-La Roche Ltd, GE Healthcare Life Sciences, I-SENS Inc.,
LifeScan Inc., Medtronic plc, MilliporeSigma, NeuroSky Inc., Nova Biomedical
Corporation, PerkinElmer Inc., Sarissa Biomedical Ltd, Sensor-Kinesis
Corporation, among others.
The
research report titled “Biosensors: A Global
Strategic Business Report” announced by Global Industry Analysts
Inc.,
provides a comprehensive review
of market trends, issues, drivers, mergers, acquisitions and other strategic industry
activities of global companies. The report provides market estimates and
projections for all major geographic markets such as the US, Canada, Japan,
Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe),
Asia-Pacific (China and Rest of Asia-Pacific) and Rest of World. The report
analyzes the Biosensors by the following Applications – Medical (Glucose
Testing and Others), Environmental and Others.
For
enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
For cutting
edge analyst reviews on top industries
Follow
us on Twitter; Connect with us on LinkedIn; Follow us on Medium
Comments
Post a Comment